Last update 08 May 2025

FR-112123

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target-
Action
inhibitors
Mechanism
Cell wall inhibitors
Therapeutic Areas
Infectious Diseases
Active Indication-
Inactive Indication
Bacterial Infections
Originator Organization
Astellas Pharma, Inc.Astellas Pharma, Inc.
Active Organization-
Inactive Organization
Astellas Pharma, Inc.Astellas Pharma, Inc.Fujisawa Pharmaceutical Co., Ltd.
License Organization-
Drug Highest PhaseDiscontinuedPreclinical
First Approval Date-
Regulation-

Structure/Sequence

Molecular FormulaC16H30N6O6
InChIKeyIJFLDLYNHBRNLJ-UHFFFAOYSA-N
CAS Registry128593-14-6

Related

100 Clinical Results associated with FR-112123
Login to view more data
100 Translational Medicine associated with FR-112123
Login to view more data
100 Patents (Medical) associated with FR-112123
Login to view more data
1
Literatures (Medical) associated with FR-112123
01 Jan 1990The Journal of AntibioticsQ4 · MEDICINE
FR112123, a new oligopeptide antibiotic from Streptomyces viridochromogenes. Taxonomy, fermentation, isolation, physico-chemical properties, structure and biological activity.
Q4 · MEDICINE
100 Deals associated with FR-112123
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Bacterial InfectionsPreclinical
Japan
Fujisawa Pharmaceutical Co., Ltd.
-
Bacterial InfectionsPreclinical-
Astellas Pharma, Inc.Astellas Pharma, Inc.
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free